Rare diseases
Investigational molecules
Locations
Back to Germany357 clinical trials in Mannheim, Germany across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)A study to evaluate the effectiveness and safety of AP707 in patients with borderline personality disorder.
GermanyGermanyPhase 3 Randomized Study of Niraparib Tosilate Monohydrate vs. Temozolomide in Newly Diagnosed MGMT Unmethylated Glioblastoma
GermanyStudy of divarasib and pembrolizumab compared to standard chemotherapy in previously untreated KRAS G12C-mutated advanced non-small cell lung cancer
GermanyStudy of TORL-1-23 and pegfilgrastim in women with advanced platinum-resistant ovarian, peritoneal, or fallopian tube cancer expressing CLDN6
GermanyStudy on Thiethylperazine and Florbetaben (18F) for Early Alzheimer's Disease Patients
GermanyStudy of Weekly Oral GS-1720 and GS-4182 for People with HIV-1 Who Are Virologically Suppressed
GermanyStudy on the Effects of Sabirnetug for Patients with Early Alzheimer's Disease
GermanyStudy on Cannabidiol as an Add-On Treatment for Patients with Early Schizophrenia
GermanyStudy on the Safety and Effectiveness of mFOLFIRINOX with or without BNT321 for Patients with Resected Pancreatic Cancer
GermanyStudy on the Safety and Effectiveness of PRI-002 for Patients with Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease
GermanyStudy Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Melanoma
GermanyThe busiest research cities in the country
What the registry says about research in the country
Clinical investigations focusing on Alzheimer's Disease and ALS, including trials of new therapeutic compounds for early-stage dementia and innovative treatments for motor neuron disease.
Research aims to improve brain amyloid clearance and evaluate new treatment approaches for neurological disorders.
Comprehensive studies in cancer treatment, including trials for gastric cancer, melanoma, and breast cancer, with a focus on targeted therapies and immunological approaches.
Advanced treatments combining immunotherapy with established protocols to improve patient outcomes.
Studies addressing inflammatory disorders, particularly focusing on Crohn's Disease, ulcerative colitis, and uveitis, testing novel therapeutic combinations.
Innovative treatment strategies aimed at improving disease management and patient quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
